Spleen News and Research

RSS
Data from pacritinib Phase 3 PERSIST-1 trial in patients with myelofibrosis to be highlighted at ASCO

Data from pacritinib Phase 3 PERSIST-1 trial in patients with myelofibrosis to be highlighted at ASCO

Results of pacritinib Phase 2 study in myelofibrosis patients published in journal 'Blood'

Results of pacritinib Phase 2 study in myelofibrosis patients published in journal 'Blood'

Recruitment completed for Phase III PROUD-PV trial of P1101 for treatment of polycythemia vera

Recruitment completed for Phase III PROUD-PV trial of P1101 for treatment of polycythemia vera

Pacritinib for myelofibrosis meets primary endpoint in Phase 3 PERSIST-1 trial

Pacritinib for myelofibrosis meets primary endpoint in Phase 3 PERSIST-1 trial

Eliglustat drug improves liver, spleen size and hemoglobin level in adults with Gaucher disease type 1

Eliglustat drug improves liver, spleen size and hemoglobin level in adults with Gaucher disease type 1

Study shows amyloid formation may link type 2 diabetes and Alzheimer disease

Study shows amyloid formation may link type 2 diabetes and Alzheimer disease

Researchers develop novel strategy in fight against cancer

Researchers develop novel strategy in fight against cancer

Farnesoid-X receptor could play key role in hepatobiliary and gastrointestinal disorders

Farnesoid-X receptor could play key role in hepatobiliary and gastrointestinal disorders

Researchers reveal link between the microbiome of young mice and later onset of autoimmune disease

Researchers reveal link between the microbiome of young mice and later onset of autoimmune disease

CML mouse model reveals previously unreported facets of disease

CML mouse model reveals previously unreported facets of disease

Low alcohol consumption, plant-based diet reduce risk of obesity-related cancers

Low alcohol consumption, plant-based diet reduce risk of obesity-related cancers

Novartis' JUMP study reinforces safety, efficacy of Jakavi (ruxolitinib) for myelofibrosis treatment

Novartis' JUMP study reinforces safety, efficacy of Jakavi (ruxolitinib) for myelofibrosis treatment

PRM-151 compound shows positive results for treating advanced myelofibrosis

PRM-151 compound shows positive results for treating advanced myelofibrosis

Researchers identify new targets for future CLL therapies

Researchers identify new targets for future CLL therapies

Jakafi receives expanded approval from FDA for use in treatment of polycythemia vera

Jakafi receives expanded approval from FDA for use in treatment of polycythemia vera

Abnormal activation of cell death pathways may lead to inflammatory skin diseases

Abnormal activation of cell death pathways may lead to inflammatory skin diseases

Strategy to stem infections in livestock, endangered species

Strategy to stem infections in livestock, endangered species

Simple blood test may help spot pancreatic cancer

Simple blood test may help spot pancreatic cancer

Roskamp Institute Discovers New Target For Drugs To Treat Alzheimer's Disease

Roskamp Institute Discovers New Target For Drugs To Treat Alzheimer's Disease

New oral biologic medication successfully treats precancerous intestinal inflammation

New oral biologic medication successfully treats precancerous intestinal inflammation

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.